FindTrial
Sign In

Study the effect of medicated enema in joint pain.

Clinicopathological assessment of Ama and Gut Microbiota with administration of Vaitaran Basti in Amavata Randomised control trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049919
Enrollment
60
Registered
2023-02-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

None listed

Sponsors

HOD of Department of Vikriti Vigyan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The patient with clinical features of Amavata mentioned in Samhitas Patient with features of aggravated Amavata mentioned in samhitas Patient who are willing to participate in this study

Exclusion criteria

Exclusion criteria: Patients associated with anal disease arsha bhagandra uncontrolled HTN and any skin disease Pregnant women Patients contraindicated for Basti as mentioned in samhitas Patients who didnâ??t complete follow up and treatment protocol Patients who are not willing to give consent will be excluded from study

Design outcomes

Primary

MeasureTime frame
To assess the efficacy of Vaitaran Basti in improvement of features of ama stage of Amavata patientsTimepoint: 7days—

Secondary

MeasureTime frame
To assess the status of ama and change in gut Microbiota with administration of Vaitaran Basti in Amavata patientsTimepoint: Before intervention(1st day) & after intervention(8th day).—

Countries

India

Contacts

Public ContactDr Priyadarshini Tewari

Faculty of Ayurveda IMS BHU

pgtpriya55@gmail.com8090029260

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026